Table 3.
Patient characteristics by whether they received the MenB vaccine*.
Characteristic | Received MenB Only or Both MenB and MenACWY Vaccines† (n = 1521) | Received MenACWY Vaccine Only† (n = 858) |
P Value |
---|---|---|---|
Age, mean (SD), y | 17.72 (1.54) | 17.47 (1.50) | < 0.001 |
Male | 828 (54.4) | 443 (51.6) | 0.188 |
Race | 0.147 | ||
White/Caucasian | 1022 (67.2) | 539 (62.8) | |
African American | 248 (16.3) | 163 (19.0) | |
Asian | 136 (8.9) | 79 (9.2) | |
Other | 79 (5.2) | 59 (6.9) | |
Don’t know/not available | 36 (2.4) | 18 (2.1) | |
Ethnicity | 0.024 | ||
Hispanic | 187 (12.3) | 135 (15.7) | |
Non-Hispanic | 1252 (82.3) | 667 (77.7) | |
Don’t know/not available | 82 (5.4) | 56 (6.5) | |
High school student | 795 (52.3) | 537 (62.6) | < 0.001 |
College/graduate student | 550 (36.2) | 202 (23.5) | < 0.001 |
Living arrangement | < 0.001 | ||
Parents | 979 (64.4) | 671 (78.2) | |
On-campus dorm | 324 (21.3) | 90 (10.5) | |
Sharing with other students/friends/roommates | 107 (7.0) | 45 (5.2) | |
Alone | 43 (2.8) | 31 (3.6) | |
Other | 8 (0.5) | 0 (0.0) | |
Don’t know | 60 (3.9) | 21 (2.4) | |
Insurance coverage | 0.008 | ||
Private/commercial | 1056 (69.4) | 589 (68.6) | |
Student healthcare plan | 111 (7.3) | 46 (5.4) | |
Medicaid | 274 (18.0) | 187 (21.8) | |
Government/VA hospital | 36 (2.4) | 11 (1.3) | |
No insurance (cash payer) | 22 (1.4) | 20 (2.3) | |
Other | 5 (0.3) | 0 (0.0) | |
Don’t know | 17 (1.1) | 5 (0.6) | |
Ever received other vaccines | |||
MenACWY 1st dose | 1144 (75.2) | 826 (96.3) | < 0.001 |
MenACWY booster dose | 1002 (65.9) | 685 (79.8) | < 0.001 |
HPV | 1045 (68.7) | 540 (62.9) | 0.004 |
Tdap | 1252 (82.3) | 787 (91.7) | < 0.001 |
Treated by a frequent MenB prescriber | 1250 (82.2) | 639 (74.5) | < 0.001 |
HCP = healthcare provider; HPV = human papilloma virus; MenACWY = meningococcal serogroups A, C, W, and Y; MenB = meningococcal serogroup B; Tdap = tetanus, diphtheria, and acellular pertussis; VA = Veterans Affairs.
P values <0.05 are indicated in bold font.
*According to chart review by HCP.
†Values are presented as n (%) unless otherwise noted.